bis[2-(ethylsulfonylamino)ethyl] (E)-but-2-enedioate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: bis[2-(ethylsulfonylamino)ethyl] (E)-but-2-enedioate
• 化学式: C₁₂H₂₂N₂O₈S₂
• 分子量: 386.447
• InChiKey: MLADGRJOMNCICF-AATRIKPKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.9
• 重原子数：
  24
• 可旋转键数：
  14
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  162
• 氢给体数：
  2
• 氢受体数：
  10

文献信息

• SULFONAMIDE AND SULFINAMIDE PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DISEASES
  申请人：Alkermes Pharma Ireland Limited

  公开号：US20150239829A1

  公开（公告）日：2015-08-27

  The present invention provides compounds and pharmaceutical compositions for treating neurological diseases such as multiple sclerosis.

  本发明提供了用于治疗神经系统疾病如多发性硬化症的化合物和药物组合物。
• FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE
  申请人：Nguyen Mark Quang

  公开号：US20170022153A1

  公开（公告）日：2017-01-26

  Fumarate compounds, pharmaceutical compositions comprising the fumarate compounds, and methods of using fumarate compounds and pharmaceutical compositions for treating neurodegenerative, inflammatory, and autoimmune disorders including multiple sclerosis, psoriasis, irritable bowel disorder, ulcerative colitis, arthritis, chronic obstructive pulmonary disease, asthma, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are disclosed.

  本发明公开了富马酸化合物、包含该富马酸化合物的药物组合物以及使用该富马酸化合物和药物组合物治疗神经退行性、炎症性和自身免疫性疾病的方法，包括多发性硬化、银屑病、肠易激综合征、溃疡性结肠炎、关节炎、慢性阻塞性肺疾病、哮喘、帕金森病、亨廷顿病和肌萎缩性侧索硬化等。
• PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DISEASES
  申请人：Alkermes Pharma Ireland Limited

  公开号：US20160137660A1

  公开（公告）日：2016-05-19

  The present invention provides compounds of formula (I), wherein: R 1 is unsubstituted C 1 -C 6 alkyl; L a is substituted or unsubstituted C 1 -C 6 alkyl linker, substituted or unsubstituted C 3 -C 10 carbocycle, substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S, or substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S; and R 2 and R 3 are each, independently, H, substituted or unsubstituted C 1 -C 6 alkyl, or substituted or unsubstituted C 6 -C 10 aryl; or alternatively, R 2 and R 3 , together with the nitrogen atom to which they are attached, form a substituted or unsubstituted heteroaryl comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S or a substituted or unsubstituted heterocycle comprising one or two 5- or 6-member rings and 1-4 heteroatoms selected from N, O and S. The invention also provides pharmaceutical compositions and methods for treating neurological diseases, such as multiple sclerosis.

  本发明提供式（I）的化合物，其中：R1是未取代的C1-C6烷基；La是取代或未取代的C1-C6烷基连接物，取代或未取代的C3-C10碳环，包含一个或两个5-或6-成员环和1-4个从N，O和S中选择的杂原子的取代或未取代的杂环，或者是取代或未取代的含有一个或两个5-或6-成员环和1-4个从N，O和S中选择的杂原子的取代或未取代的杂芳基；R2和R3各自独立地是H，取代或未取代的C1-C6烷基，或取代或未取代的C6-C10芳基；或者，R2和R3与它们附着的氮原子一起形成取代或未取代的杂芳基，其中包括一个或两个5-或6-成员环和1-4个从N，O和S中选择的杂原子，或取代或未取代的含有一个或两个5-或6-成员环和1-4个从N，O和S中选择的杂原子的杂环。本发明还提供用于治疗神经系统疾病，如多发性硬化症的药物组合物和方法。
• Prodrugs of fumarates and their use in treating various diseases
  申请人：Alkermes Pharma Ireland Limited

  公开号：US10080733B2

  公开（公告）日：2018-09-25

  The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.

  本发明提供了式 (I) 化合物及其药物组合物。
• Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases
  申请人：Alkermes Pharma Ireland Limited

  公开号：US10301256B2

  公开（公告）日：2019-05-28

  The present invention provides compounds and pharmaceutical compositions for treating neurological diseases such as multiple sclerosis.

  本发明提供了用于治疗神经系统疾病（如多发性硬化症）的化合物和药物组合物。